Marin-Serrano E, Barbado CA. Intraductal papillary neoplasm of the bile duct: a recurring disease. Rev Esp Enferm Dig. 2019;111(11):890–1.
Nakanuma Y, Sudo Y. Biliary tumors with pancreatic counterparts. Semin Diagn Pathol. 2017;34(2):167–75.
Nakanuma Y, Uesaka K, Kakuda Y, Sugino T, Kubota K, Furukawa T, et al. Intraductal papillary neoplasm of bile duct: updated clinicopathological characteristics and molecular and genetic alterations. J Clin Med. 2020;9(12):1.
Fujikura K, Fukumoto T, Ajiki T, Otani K, Kanzawa M, Akita M, et al. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas. Histopathology. 2016;69(6):950–61.
Wu X, Li B, Zheng C. Clinicopathologic characteristics and long-term prognosis of intraductal papillary neoplasm of the bile duct: a retrospective study. Eur J Med Res. 2023;28(1):132.
Article CAS PubMed PubMed Central Google Scholar
Ainechi S, Lee H. Updates on precancerous lesions of the biliary tract: biliary precancerous lesion. Arch Pathol Lab Med. 2016;140(11):1285–9.
Kim JR, Jang KT, Jang JY. Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics. Br J Surg. 2023;110(9):1229–40.
Kubota K, Nakanuma Y, Kondo F, Hachiya H, Miyazaki M, Nagino M, et al. Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association. J Hepatobiliary Pancreat Sci. 2014;21(3):176–85.
Lluís N, Serradilla-Martín M, Achalandabaso M, Jehaes F, Dasari BVM, Mambrilla-Herrero S, et al. Intraductal papillary neoplasms of the bile duct: a European retrospective multicenter observational study (EUR-IPNB study). Int J Surg. 2023;109(4):760–71.
Article PubMed PubMed Central Google Scholar
Rocha FG, Lee H, Katabi N, DeMatteo RP, Fong Y, D’Angelica MI, et al. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology. 2012;56(4):1352–60.
Article CAS PubMed Google Scholar
D’Souza MA, Isaksson B, Löhr M, Enochsson L, Swahn F, Lundell L, Arnelo U. The clinicopathological spectrum and management of intraductal papillary mucinous neoplasm of the bile duct (IPMN-B). Scand J Gastroenterol. 2013;48(4):473–9.
Horm TM, Schroeder JA. MUC1 and metastatic cancer: expression, function and therapeutic targeting. Cell Adh Migr. 2013;7(2):187–98.
Article PubMed PubMed Central Google Scholar
Ohtsuka M, Shimizu H, Kato A, Yoshitomi H, Furukawa K, Tsuyuguchi T, et al. Intraductal papillary neoplasms of the bile duct. Int J Hepatol. 2014;2014:459091.
Article PubMed PubMed Central Google Scholar
Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, Marchegiani G, et al. Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of Verona consensus meeting. Ann Surg. 2016;263(1):162–77.
Bennett S, Marginean EC, Paquin-Gobeil M, Wasserman J, Weaver J, Mimeault R, et al. Clinical and pathological features of intraductal papillary neoplasm of the biliary tract and gallbladder. HPB (Oxford). 2015;17(9):811–8.
Höhn P, Braumann C, Munding J, Tannapfel A, Uhl W, Künzli BM. Outcome determining factors of intraductal papillary neoplasm of the biliary tract (IPNB)—a single center survey and analysis of current literature. J Gastrointest Cancer. 2019;50(1):160–9.
Nakanuma Y, Jang KT, Fukushima N, Furukawa T, Hong SM, Kim H, et al. A statement by the Japan–Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage. J Hepatobiliary Pancreat Sci. 2018;25(3):181–7.
Aoki Y, Mizuma M, Hata T, Aoki T, Omori Y, Ono Y, et al. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes. J Pathol. 2020;251(1):38–48.
Article CAS PubMed Google Scholar
Harada F, Matsuyama R, Mori R, Kumamoto T, Morioka D, Taguri M, et al. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: case–control study of a single Japanese institution’s experience with special attention to mucin expression patterns. Eur J Surg Oncol. 2019;45(5):761–8.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.
Riley RD, Moons KGM, Snell KIE, Ensor J, Hooft L, Altman DG, et al. A guide to systematic review and meta-analysis of prognostic factor studies. BMJ. 2019;364:k4597.
Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Datab Syst Rev 10(10):Ed000142
Kim JR, Jang KT, Jang JY, Lee K, Kim JH, Kim H, et al. Clinicopathologic analysis of intraductal papillary neoplasm of bile duct: Korean multicenter cohort study. HPB (Oxford). 2020;22(8):1139–48.
Kim JR, Lee KB, Kwon W, Kim E, Kim SW, Jang JY. Comparison of the clinicopathologic characteristics of intraductal papillary neoplasm of the bile duct according to morphological and anatomical classifications. J Korean Med Sci. 2018;33(42):e266.
Article PubMed PubMed Central Google Scholar
Luvira V, Pugkhem A, Bhudhisawasdi V, Pairojkul C, Sathitkarnmanee E, Luvira V, Kamsa-Ard S. Long-term outcome of surgical resection for intraductal papillary neoplasm of the bile duct. J Gastroenterol Hepatol. 2017;32(2):527–33.
Jung G, Park KM, Lee SS, Yu E, Hong SM, Kim J. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct. J Hepatol. 2012;57(4):787–93.
Uemura S, Higuchi R, Yazawa T, Izumo W, Matsunaga Y, Shiihara M, et al. Prognostic factors for surgically resected intraductal papillary neoplasm of the bile duct: a retrospective cohort study. Ann Surg Oncol. 2021;28(2):826–34.
Youn JM, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, et al. Clinicopathological features and long-term outcomes of intraductal papillary neoplasms of the bile duct of the liver: single-institution experience with 146 patients. J Gastrointest Surg. 2022;26(7):1394–405.
Lee S, Kim MJ, Kim S, Choi D, Jang KT, Park YN. Intraductal papillary neoplasm of the bile duct: assessment of invasive carcinoma and long-term outcomes using MRI. J Hepatol. 2019;70(4):692–9.
Matsumoto T, Kubota K, Hachiya H, Sakuraoka Y, Shiraki T, Shimizu T, et al. Impact of tumor location on postoperative outcome of intraductal papillary neoplasm of the bile duct. World J Surg. 2019;43(5):1313–22.
Kubota K, et al. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study. J Hepatobiliary Pancreat Sci. 2020;27(9):581–597
Nakanuma Y, Uesaka K, Okamura Y, Terada T, Fukumura Y, Kakuda Y, et al. Reappraisal of pathological features of intraductal papillary neoplasm of bile duct with respect to the type 1 and 2 subclassifications. Hum Pathol. 2021;111:21–35.
Article CAS PubMed Google Scholar
Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Kato A, Yoshitomi H, et al. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg Pathol. 2011;35(4):512–21.
Onoe S, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, et al. A clinicopathological reappraisal of intraductal papillary neoplasm of the bile duct (IPNB): a continuous spectrum with papillary cholangiocarcinoma in 181 curatively resected cases. HPB (Oxford). 2021;23(10):1525–32.
留言 (0)